{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:25:42Z","timestamp":1740029142160,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,19]]},"DOI":"10.7759\/cureus.79327","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T03:40:13Z","timestamp":1740022813000},"source":"Crossref","is-referenced-by-count":0,"title":["Progressive Muscle Weakness and Dysphagia in Late-Onset Systemic Lupus Erythematosus: A Case Report"],"prefix":"10.7759","author":[{"given":"Sho","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasumi","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2165\/11598550-000000000-00000","article-title":"Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment","volume":"29","author":"Arnaud L","year":"2012","unstructured":"Arnaud L, Mathian A, Boddaert J, Amoura Z. Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment. Drugs Aging. 2012, 29:181-9. 10.2165\/11598550-000000000-00000","journal-title":"Drugs Aging"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100129","article-title":"Autoimmune rheumatic diseases: one or many diseases?","volume":"4","author":"Moutsopoulos HM","year":"2021","unstructured":"Moutsopoulos HM. Autoimmune rheumatic diseases: one or many diseases?. J Transl Autoimmun. 2021, 4:100129. 10.1016\/j.jtauto.2021.100129","journal-title":"J Transl Autoimmun"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer M","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, et al.. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019, 71:1400-12. 10.1002\/art.40930","journal-title":"Arthritis Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients","volume":"82","author":"Cervera R","year":"2003","unstructured":"Cervera R, Khamashta MA, Font J, et al.. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore). 2003, 82:299-308. 10.1097\/01.md.0000091181.93122.55","journal-title":"Medicine (Baltimore)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead617","article-title":"Multimorbidity in systemic lupus erythematosus in a population-based cohort: the Lupus Midwest Network","volume":"63","author":"Figueroa-Parra G","year":"2024","unstructured":"Figueroa-Parra G, Meade-Aguilar JA, Hulshizer CA, et al.. Multimorbidity in systemic lupus erythematosus in a population-based cohort: the Lupus Midwest Network. Rheumatology (Oxford). 2024, 63:3056-64. 10.1093\/rheumatology\/kead617","journal-title":"Rheumatology (Oxford)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320967102","article-title":"Multimorbidity among incident Finnish systemic lupus erythematosus patients during 2000-2017","volume":"30","author":"Kariniemi S","year":"2021","unstructured":"Kariniemi S, Rantalaiho V, Virta LJ, Puolakka K, Sokka-Isler T, Elfving P. Multimorbidity among incident Finnish systemic lupus erythematosus patients during 2000-2017. Lupus. 2021, 30:165-71. 10.1177\/0961203320967102","journal-title":"Lupus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007040422","article-title":"Age affects outcomes in chronic kidney disease","volume":"18","author":"O'Hare AM","year":"2007","unstructured":"O'Hare AM, Choi AI, Bertenthal D, et al.. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007, 18:2758-65. 10.1681\/ASN.2007040422","journal-title":"J Am Soc Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_502_20","article-title":"Cutaneous manifestations of chronic kidney disease, dialysis and post-renal transplant: a review","volume":"66","author":"Goel V","year":"2021","unstructured":"Goel V, Sil A, Das A. Cutaneous manifestations of chronic kidney disease, dialysis and post-renal transplant: a review. Indian J Dermatol. 2021, 66:3-11. 10.4103\/ijd.IJD_502_20","journal-title":"Indian J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4081\/cp.2011.e89","article-title":"Systemic lupus erythematosusmyositis overlap syndrome: report of 6 cases","volume":"1","author":"Maazoun F","year":"2011","unstructured":"Maazoun F, Frikha F, Snoussi M, Kaddour N, Masmoudi H, Bahloul Z. Systemic lupus erythematosusmyositis overlap syndrome: report of 6 cases. Clin Pract. 2011, 1:e89. 10.4081\/cp.2011.e89","journal-title":"Clin Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: an important tool to support diagnosis of myositis","volume":"280","author":"Betteridge Z","year":"2016","unstructured":"Betteridge Z, McHugh N. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med. 2016, 280:8-23. 10.1111\/joim.12451","journal-title":"J Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/267078","article-title":"Immunosenescence, aging, and systemic lupus erythematous","volume":"2013","author":"Montoya-Ortiz G","year":"2013","unstructured":"Montoya-Ortiz G. Immunosenescence, aging, and systemic lupus erythematous. Autoimmune Dis. 2013, 2013:267078. 10.1155\/2013\/267078","journal-title":"Autoimmune Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.15190\/d.2022.19","article-title":"Proximal myopathy: causes and associated conditions","volume":"10","author":"Rao A","year":"2022","unstructured":"Rao A, Nawaz I, Arbi FM, Ishtiaq R. Proximal myopathy: causes and associated conditions. Discoveries (Craiova). 2022, 10:e160. 10.15190\/d.2022.19","journal-title":"Discoveries (Craiova)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191610125","article-title":"Relationship between dysphagia and home discharge among older patients receiving hospital rehabilitation in rural Japan: a retrospective cohort study","volume":"19","author":"Ohta R","year":"2022","unstructured":"Ohta R, Weiss E, Mekky M, Sano C. Relationship between dysphagia and home discharge among older patients receiving hospital rehabilitation in rural Japan: a retrospective cohort study. Int J Environ Res Public Health. 2022, 19:10.3390\/ijerph191610125","journal-title":"Int J Environ Res Public Health"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18168443","article-title":"The contribution of temporal flat lateral position on the mortality and discharge rates of older patients with severe dysphagia","volume":"18","author":"Shimizu A","year":"2021","unstructured":"Shimizu A, Ohta R, Otani H, Sano C. The contribution of temporal flat lateral position on the mortality and discharge rates of older patients with severe dysphagia. Int J Environ Res Public Health. 2021, 18:10.3390\/ijerph18168443","journal-title":"Int J Environ Res Public Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.06.010","article-title":"Immunomodulators in SLE: clinical evidence and immunologic actions","volume":"74","author":"Durcan L","year":"2016","unstructured":"Durcan L, Petri M. Immunomodulators in SLE: clinical evidence and immunologic actions. J Autoimmun. 2016, 74:73-84. 10.1016\/j.jaut.2016.06.010","journal-title":"J Autoimmun"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-023-03232-2","article-title":"Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study","volume":"26","author":"Aggarwal R","year":"2024","unstructured":"Aggarwal R, Schessl J, Charles-Schoeman C, et al.. Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study. Arthritis Res Ther. 2024, 26:27. 10.1186\/s13075-023-03232-2","journal-title":"Arthritis Res Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X211073001","article-title":"Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge","volume":"14","author":"Dima A","year":"2022","unstructured":"Dima A, Jurcut C, Chasset F, Felten R, Arnaud L. Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge. Ther Adv Musculoskelet Dis. 2022, 14:1759720X211073001. 10.1177\/1759720X211073001","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.73726","article-title":"Effectiveness of general medicine in the management of rheumatoid arthritis in rural settings: a systematic review and meta-ethnography","volume":"16","author":"Ohta R","year":"2024","unstructured":"Ohta R, Sano C. Effectiveness of general medicine in the management of rheumatoid arthritis in rural settings: a systematic review and meta-ethnography. Cureus. 2024, 16:e73726. 10.7759\/cureus.73726","journal-title":"Cureus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-024-02540-z","article-title":"Evolution of the roles of family physicians through collaboration with rehabilitation therapists in rural community hospitals: a grounded theory approach","volume":"25","author":"Ohta R","year":"2024","unstructured":"Ohta R, Yoshioka K, Sano C. Evolution of the roles of family physicians through collaboration with rehabilitation therapists in rural community hospitals: a grounded theory approach. BMC Prim Care. 2024, 25:283. 10.1186\/s12875-024-02540-z","journal-title":"BMC Prim Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-024-02379-4","article-title":"Role of family medicine physicians in providing nutrition support to older patients admitted to orthopedics departments: a grounded theory approach","volume":"25","author":"Ohta R","year":"2024","unstructured":"Ohta R, Nitta T, Shimizu A, Sano C. Role of family medicine physicians in providing nutrition support to older patients admitted to orthopedics departments: a grounded theory approach. BMC Prim Care. 2024, 25:121. 10.1186\/s12875-024-02379-4","journal-title":"BMC Prim Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/342141-progressive-muscle-weakness-and-dysphagia-in-late-onset-systemic-lupus-erythematosus-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T03:40:14Z","timestamp":1740022814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/342141-progressive-muscle-weakness-and-dysphagia-in-late-onset-systemic-lupus-erythematosus-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.79327","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,19]]}}}